[HTML][HTML] Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “ …

J Fokam, SM Sosso, B Yagai, SC Billong… - AIDS research and …, 2019 - Springer
Background After the launching of the «Test & Treat» strategy and the wider accessibility to
viral load (VL), evaluating virological success (VS) would help in meeting the UNAIDS …

[HTML][HTML] Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic …

SC Billong, J Fokam, CI Penda, S Amadou… - BMC Infectious …, 2016 - Springer
Background Retention on lifelong antiretroviral therapy (ART) is essential in sustaining
treatment success while preventing HIV drug resistance (HIVDR), especially in resource …

[PDF][PDF] The declining trend of HIV-Infection among pregnant women in Cameroon infers an epidemic decline in the general population

SC Billong, J Fokam, J de Dieu Anoubissi, CK Nde… - Heliyon, 2020 - cell.com
Background HIV remains a generalised epidemic in Cameroon, with regular sentinel
surveillance surveys (SSS) conducted among pregnant women to monitor the …

PO 8397 Viral suppression among cameroonian adults, adolescents and children receiving antiretroviral therapy in the 'test & treat'era

J Fokam, SM Sosso, RED Mbadie, Y Bouba, RK Simo… - 2019 - gh.bmj.com
Background Global efforts in meeting the 90–90–90 targets reveal that 70% of infected
people know their HIV status, 77% of these are receiving antiretroviral therapy (ART) and …

[HTML][HTML] Évaluation de la Cascade Nationale des Soins VIH et Sida du Cameroun

SC Billong, A Zeh, CI Penda, I Diallo… - HEALTH SCIENCES …, 2019 - hsd-fmsb.org
Contexte. Avec une prévalence estimée en 2016 à 3, 8%, l'épidémie du VIH au Cameroun
reste généralisée. Ainsi, en fin 2016, les besoins populationnels de couverture du traitement …